Marshak Richard 5
5 · TriSalus Life Sciences, Inc. · Filed Jul 1, 2026
Insider Transaction Report
Form 5
Marshak Richard
Chief Commercial Officer
Transactions
- Award
Common Stock
[F1]2024-06-30$4.69/sh+279$1,309→ 27,530 total - Award
Common Stock
[F1]2024-12-31$4.26/sh+999$4,256→ 35,404 total - Award
Common Stock
[F1]2025-06-30$4.23/sh+930$3,934→ 71,309 total - Award
Common Stock
[F1]2025-12-31$4.38/sh+449$1,967→ 131,758 total
Footnotes (1)
- [F1]Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Signature
/s/ Mary Szela, Attorney-in-Fact|2026-07-01